Dixon Mitchell Investment Counsel Inc. Bruker Corp Transaction History

Dixon Mitchell Investment Counsel Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2014 Jan 17, 2024	BUY	N/A	1,700 Added 4.71%	37,820 $918 Million
Q1 2014 Jan 17, 2024	SELL	N/A	-15,400 Reduced 29.89%	36,120 $823 Million
Q4 2013 Jan 17, 2024	BUY	N/A	9,000 Added 21.17%	51,520 $1.02 Billion
Q3 2013 Jan 17, 2024	SELL	N/A	-990 Reduced 2.28%	42,520 $878 Million
Q2 2013 Jan 17, 2024	BUY	N/A	25,600 Added 142.94%	43,510 $703 Million
Q1 2013 Jan 17, 2024	SELL	N/A	-13,780 Reduced 43.48%	17,910 $342 Million
Q4 2012 Jan 17, 2024	BUY	N/A	5,050 Added 18.96%	31,690 $483 Million
Q3 2012 Jan 17, 2024	BUY	N/A	1,290 Added 5.09%	26,640 $349 Million
Q2 2012 Jan 17, 2024	BUY	N/A	7,150 Added 39.29%	25,350 $337 Million
Q1 2012 Jan 17, 2024	BUY	N/A	18,200	18,200 $279 Million

386

101M

33K

39.5K

Ticker BRKR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 148,138,000
Market Cap $8.56B
Description
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.